Colorectal Cancer

Titlesort descending Average Rating
Anti-angiogenic therapies for metastatic colorectal cancer. 60.00%
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. 40.00%
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib. 50.00%
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a stu 70.00%
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal...... 60.00%
To widen the setting of cancer patients who could benefit from metronomic capecitabine. 80.00%
A case of metronomic chemotherapy as an alternative cancer therapy for palliation 60.00%
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 50.00%
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot 70.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable m 100.00%
A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma. 100.00%
An Internet misadventure: bloodroot salve toxicity 80.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). 70.00%
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? 60.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. 80.00%
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. 80.00%
Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercriti 80.00%
Artemisinin derivates in the treatment of Cancer 90.00%
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glyc 60.00%
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal 50.00%
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in--- 80.00%
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. 70.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) 80.00%
Complete remission of psoriasis following bevacizumab therapy for colon cancer. 60.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients 70.00%
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthe.... 80.00%
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. 50.00%
Homeopathy as a supportive therapy in cancer. 70.00%
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. 70.00%
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". 60.00%
Low-dose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. 70.00%
Melatonin as biological response modifier in cancer patients. 80.00%
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 90.00%
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high... 80.00%
Mycoplasma infections and different human carcinomas. 90.00%
Nuts and green tea key to cancer treatment? 60.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. 90.00%
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. 70.00%
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory....... 70.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.. 80.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative....
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced 90.00%
Sorafenib and radiation: A promising combination in colorectal and pancreas cancer 70.00%
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. 60.00%
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications 90.00%
The present state of antineoplaston research (1) 90.00%
Todoxin, the immune stimulant from Serbia 86.36%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%